Robyn Rapaport

Insider Reports History

Entity
Individual
Location
Cero Therapeutics Holdings, Inc., 2201 Broadway, Suite 705, Oakland, CA
Signature
/s/ Charles Carter, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robyn Rapaport:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CERO THERAPEUTICS HOLDINGS, INC. Director Stock Option (Right to Buy) 113K Mar 25, 2024 Direct
PHOENIX BIOTECH ACQUISITION CORP. Director Common Stock 50K Feb 14, 2024 Direct

Insider Reports Filed by Robyn Rapaport

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERO CERO THERAPEUTICS HOLDINGS, INC. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 0 $0 3 Feb 16, 2024 Director